Screener

Research And Development Expense

Name: Axsome Therapeutics Research And Development Expense by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Axsome Therapeutics·Products & Services·2 segments·Rolls up to R&D

Breakdown

Segment	Q4 '25	Q1 '26
Balipodect	—	$10.4M
AZD7325	$2.3M	—
Total	$48.79M	$52.68M

Segments

AZD7325View metric

BalipodectView metric